Differential expression of cyclooxygenase 2 in human colorectal cancer
View abstract on PubMed
Summary
This summary is machine-generated.Colorectal cancer shows higher cyclooxygenase 2 (COX-2) protein levels in rectal tumors compared to other colon locations. This differential COX-2 expression in colorectal cancer may impact tumor progression and treatment strategies.
Area Of Science
- Oncology
- Molecular Biology
- Gastroenterology
Background
- Arachidonic acid metabolites, like prostaglandin E(2) (PGE(2)), are implicated in colorectal carcinogenesis.
- Cyclooxygenase 2 (COX-2), an enzyme in PGE(2) synthesis, is upregulated in colorectal cancer.
Purpose Of The Study
- To investigate differential cyclooxygenase 2 (COX-2) expression across various colorectal cancer locations.
- To compare COX-2 protein levels in tumors from the caecum, ascending, transverse, descending, sigmoid colon, and rectum.
Main Methods
- Western blot analysis was used to quantify COX-2 protein levels.
- Tumor and adjacent normal mucosa samples from 39 colorectal cancer patients were analyzed.
Main Results
- A significant overexpression of COX-2 protein was observed in rectal tumors (p<0.001) compared to other colon sites.
- Elevated COX-2 protein levels were found in 18/20 rectal tumors versus 4/19 colonic tumors.
- No correlation was found between COX-2 expression and Dukes's stages in colorectal cancer.
Conclusions
- Differential COX-2 expression in colorectal cancer suggests variations in gene regulation or secondary tumor progression changes.
- These findings may have clinical implications for understanding and treating colorectal cancer based on tumor location.